Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 08, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000054.pdf 0001883850-22-000054.xls
Aug 03, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-22-000020.pdf 0001804220-22-000020.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-22-000023.pdf 0001804220-22-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000050.pdf 0001883850-22-000050.xls
Jul 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000048.pdf 0001883850-22-000048.xls
Jun 15, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-071446.pdf 0001104659-22-071446.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 03, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000042.pdf 0001708138-22-000042.xls
Jun 02, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-067375.pdf 0001104659-22-067375.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 31, 2022	SC TO-T/A	Amendment to a previously filed SC TO-T	View HTML 0001104659-22-066277.pdf 0001104659-22-066277.xls
May 20, 2022	SC TO-T/A	Amendment to a previously filed SC TO-T	View HTML 0001104659-22-063410.pdf 0001104659-22-063410.xls

Data provided by Kaleidoscope.

Investors & Media